Andreea Varga

3.2k total citations
60 papers, 470 citations indexed

About

Andreea Varga is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Andreea Varga has authored 60 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cardiology and Cardiovascular Medicine, 20 papers in Pulmonary and Respiratory Medicine and 20 papers in Oncology. Recurrent topics in Andreea Varga's work include Cancer Immunotherapy and Biomarkers (11 papers), Cardiovascular Function and Risk Factors (6 papers) and Blood Pressure and Hypertension Studies (6 papers). Andreea Varga is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Cardiovascular Function and Risk Factors (6 papers) and Blood Pressure and Hypertension Studies (6 papers). Andreea Varga collaborates with scholars based in Romania, France and United States. Andreea Varga's co-authors include Ioan Ţilea, Laura Mezquita, Jean‐Charles Soria, Alexandru Burlacu, David Planchard, Antoine Hollebecque, Septimiu Voidăzan, Capucine Baldini, Christophe Massard and Aurélien Marabelle and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Andreea Varga

50 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreea Varga Romania 13 168 118 94 86 53 60 470
Stefanie Senger United States 13 150 0.9× 174 1.5× 128 1.4× 242 2.8× 79 1.5× 20 588
Josephina G. Kuiper Netherlands 13 182 1.1× 110 0.9× 63 0.7× 71 0.8× 87 1.6× 37 640
S. Seber Türkiye 13 142 0.8× 78 0.7× 130 1.4× 94 1.1× 84 1.6× 56 516
Barbara Iyen United Kingdom 11 140 0.8× 192 1.6× 52 0.6× 53 0.6× 147 2.8× 27 520
Emily Robinson United States 9 159 0.9× 166 1.4× 181 1.9× 234 2.7× 37 0.7× 15 588
Clara García-Carro Spain 12 82 0.5× 80 0.7× 90 1.0× 49 0.6× 115 2.2× 28 499
Jianhong Zhu China 10 136 0.8× 174 1.5× 85 0.9× 29 0.3× 85 1.6× 43 546
Stefania Mantarro Italy 11 201 1.2× 75 0.6× 52 0.6× 114 1.3× 61 1.2× 17 470

Countries citing papers authored by Andreea Varga

Since Specialization
Citations

This map shows the geographic impact of Andreea Varga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreea Varga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreea Varga more than expected).

Fields of papers citing papers by Andreea Varga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreea Varga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreea Varga. The network helps show where Andreea Varga may publish in the future.

Co-authorship network of co-authors of Andreea Varga

This figure shows the co-authorship network connecting the top 25 collaborators of Andreea Varga. A scholar is included among the top collaborators of Andreea Varga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreea Varga. Andreea Varga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yap, Timothy A., Olivier Rixe, Capucine Baldini, et al.. (2025). First‐in‐human phase 1 study of KHK2455 monotherapy and in combination with mogamulizumab in patients with advanced solid tumors. Cancer. 131(13). e35939–e35939. 2 indexed citations
2.
3.
Varga, Andreea, et al.. (2024). Kidney Dysfunction, Hepatic Impairment, and Lipid Metabolism Abnormalities in Patients with Precapillary Pulmonary Hypertension. Diagnostics. 14(16). 1824–1824. 1 indexed citations
4.
Meric‐Bernstam, Funda, Yoichi Naito, Stéphanie Gaillard, et al.. (2024). 606O Initial results from a first-in-human study of the B7-H4-directed antibody-drug conjugate (ADC) AZD8205 (puxitatug samrotecan) in patients with advanced/metastatic solid tumors. Annals of Oncology. 35. S485–S486. 7 indexed citations
5.
Brînzaniuc, Klara, et al.. (2023). The Gender Gap in Aortic Dissection: A Prospective Analysis of Risk and Outcomes. ˜The œJournal of Critical Care Medicine. 9(3). 178–186. 2 indexed citations
6.
7.
Chirilă, Sergiu, et al.. (2023). Assessing the Effects of Medical Information on Parental Self-Medication Behaviors for Children’s Health: A Comparative Analysis. Medicina. 59(12). 2093–2093. 1 indexed citations
8.
Baldini, Capucine, Andreea Varga, Séverine Mouraud, et al.. (2021). 1732MO Pembrolizumab and nintedanib for patients with advanced mesothelioma. Annals of Oncology. 32. S1198–S1198.
9.
Ţilea, Ioan, et al.. (2021). Short-Term Impact of Iron Deficiency in Different Subsets of Patients with Precapillary Pulmonary Hypertension from an Eastern European Pulmonary Hypertension Referral Center. International Journal of General Medicine. Volume 14. 3355–3366. 4 indexed citations
10.
Ţilea, Ioan, et al.. (2021). Critical Care Management of Decompensated Right Heart Failure in Pulmonary Arterial Hypertension Patients – An Ongoing Approach. SHILAP Revista de lepidopterología. 7(3). 170–183. 6 indexed citations
11.
Baldini, Capucine, P. Martin Romano, Anne-Laure Voisin, et al.. (2020). Impact of aging on immune-related adverse events generated by anti–programmed death (ligand)PD-(L)1 therapies. European Journal of Cancer. 129. 71–79. 63 indexed citations
12.
Romano, P. Martin, Laura Mezquita, Ludovic Lacroix, et al.. (2020). 1930O Genomic alterations in solid tumours according to ESMO scale for clinical actionability of molecular targets (ESCAT). Annals of Oncology. 31. S1092–S1093. 5 indexed citations
13.
Bernard‐Tessier, Alice, Capucine Baldini, Eduardo Castañón, et al.. (2020). Patterns of progression in patients treated for immuno-oncology antibodies combination. Cancer Immunology Immunotherapy. 70(1). 221–232. 15 indexed citations
14.
Martín-Romano, Patricia, Samy Ammari, Capucine Baldini, et al.. (2020). Chemotherapy beyond immune checkpoint inhibitors in patients with metastatic colorectal cancer. European Journal of Cancer. 137. 117–126. 15 indexed citations
15.
Baldini, Capucine, P. Martin Romano, Andreea Varga, et al.. (2018). Immunothérapie des glioblastomes. Bulletin du Cancer. 105. S59–S67.
16.
Hollebecque, Antoine, Andreea Varga, Capucine Baldini, et al.. (2018). Organisational factors influencing early clinical trials enrollment: Gustave Roussy experience. European Journal of Cancer. 98. 17–22. 11 indexed citations
17.
Castañón, Eduardo, Valérie Dyevre, Sandrine Aspeslagh, et al.. (2017). Immunotherapy phase I trials in patients over 70 years with advanced solid tumours: The Gustave Roussy experience. Annals of Oncology. 28. v413–v413. 1 indexed citations
18.
Bigot, Frédéric, Antoine Hollebecque, Alberto Carmona‐Bayonas, et al.. (2016). Identification of new prognostic factors in phase I patients treated by immunotherapy. Annals of Oncology. 27. vi124–vi124. 2 indexed citations
19.
Massard, C., Joaquı́n Mateo, Yohann Loriot, et al.. (2016). Phase I/II trial of cabazitaxel plus abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel and abiraterone. Annals of Oncology. 28(1). 90–95. 20 indexed citations
20.
Varga, Andreea, et al.. (1998). Does atherosclerosis observed by routine scanning of the descending aorta during transesophageal echocardiography predict cardiovascular events?. Journal of the American College of Cardiology. 31. 40–40. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefanie Senger Breakdown of academic impact, for papers by Josephina G. Kuiper Breakdown of academic impact, for papers by S. Seber Breakdown of academic impact, for papers by Barbara Iyen Breakdown of academic impact, for papers by Emily Robinson Breakdown of academic impact, for papers by Clara García-Carro Breakdown of academic impact, for papers by Jianhong Zhu Breakdown of academic impact, for papers by Stefania Mantarro
Rankless by CCL
2026